WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Bo Chen
Patent Counselor
Patents and Innovations
Shanghai
bchen@wsgr.com

D86-21-6165-1700

Download vCard
Open PDF

Bo Chen is a patent counselor in the Shanghai office of Wilson Sonsini Goodrich & Rosati. Bo's practice focuses on patent prosecution and strategic intellectual property counseling in the mechanics and electronics industries. He has particular expertise in IP related to circuits, mobile devices, motor control, automotive parts, home appliances, and medical devices.

Prior to joining the firm, Bo was a partner at the patent boutique Beijing F&S IP Law. He also worked as an associate in China Sinda IP Agency Ltd, an IP-related judicial appraiser before court in China, and as an integrated circuit design engineer for Infineon Technologies in Germany.

Experience

Bo Chen is a patent counselor in the Shanghai office of Wilson Sonsini Goodrich & Rosati. Bo's practice focuses on patent prosecution and strategic intellectual property counseling in the mechanics and electronics industries. He has particular expertise in IP related to circuits, mobile devices, motor control, automotive parts, home appliances, and medical devices.

Prior to joining the firm, Bo was a partner at the patent boutique Beijing F&S IP Law. He also worked as an associate in China Sinda IP Agency Ltd, an IP-related judicial appraiser before court in China, and as an integrated circuit design engineer for Infineon Technologies in Germany.

Education
  • LL.M., University of California, Berkeley, 2017
  • M.Sc., Electronics Engineering, Queen's University Belfast, U.K., 2004
  • B.Sc., Electronics and Information Engineering, Dalian University of Technology, China, 2002
Admissions
  • Qualified in State Intellectual Property Office of the People's Republic of China
Credentials
Education
  • LL.M., University of California, Berkeley, 2017
  • M.Sc., Electronics Engineering, Queen's University Belfast, U.K., 2004
  • B.Sc., Electronics and Information Engineering, Dalian University of Technology, China, 2002
Admissions
  • Qualified in State Intellectual Property Office of the People's Republic of China

Diagnostics and Medical Devices

  • Biomedical devices
  • Biomedical engineering
  • Biosensors
  • Diagnostics
  • Digital pathology
  • Medical devices
  • Medical imaging
  • Wearable analyte sensors

Engineering and Technology

  • Electrical engineering
  • Mechanical engineering
  • Microfluidics
  • Robotics
Technical Fluency

Diagnostics and Medical Devices

  • Biomedical devices
  • Biomedical engineering
  • Biosensors
  • Diagnostics
  • Digital pathology
  • Medical devices
  • Medical imaging
  • Wearable analyte sensors

Engineering and Technology

  • Electrical engineering
  • Mechanical engineering
  • Microfluidics
  • Robotics
Focus Areas
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Firm Advises ScienTech Medical on US$83.4 Million IPO
On November 8, 2022, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (ScienTech Medical) successfully listed on the Main Board of the Stock Exchange of Hong Kong, raising approximately HK$654.6 million (US$83.4 million) from a global offering of 22,455,000 H shares, or approximately HK$752.7 million (US$95.9 million) if the underwriters fully exercise their over-allotment option to purchase 3,368,000 additional H shares. Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to ScienTech Medical in the global offering and listing.
Learn More
Client Highlights
Wilson Sonsini Advises PacBio on Omniome Acquisition, Private Placement and Intended Collaboration Expansion with Invitae
On July 20, 2021, Pacific Biosciences of California (PacBio), a leading provider of high-quality, long-read sequencing platforms, announced that it has signed a definitive merger agreement to acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy. Upon closing of the acquisition, PacBio will be uniquely positioned as the only company with both highly accurate long-read and short-read sequencing platforms. The company also announced two other transactions: a private placement for aggregate proceeds of approximately $300 million in connection with the proposed acquisition, and an intent to expand a multi-year collaboration with Invitae Corporation to develop a production-scale high-throughput HiFi sequencing platform to include the sequencing technology developed by Omniome.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.